A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants-Reference-Cited by-同舟云学术

A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants

Published:2023-03 Issue:10 Volume:41 Page:1753-1759
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Ok Baik Yeong,Lee Youngjin,Lee Chankyu,Kyung Kim Soo,Park Jooyoung,Sun Meixiang,Jung DaYe,Young Jang Jin,Jun Yong Tae,Woo Park Jeong,Jeong Sungho,Lim Suwon,Hyun Han Seung,Keun Choi Seuk

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. Global typhoid fever incidence: a systematic review and meta-analysis;Marchello;Clin Infect Dis,2019

2. CDC. Typhoid Fever and Paratyphoid Fever. 2021 March 30, 2021 [cited 2021 March 10, 2022].

3. Typhoid fever;Parry;N Engl J Med,2002

4. Salmonella pathogenesis and processing of secreted effectors by caspase-3;Srikanth;Science,2010

5. Spatial and temporal patterns of typhoid and paratyphoid fever outbreaks: a worldwide review, 1990–2018;Kim;Clin Infect Dis,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Typhoid Conjugate Vaccine: A Boon for Endemic Regions;Cureus;2024-03-19

2. The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria;Vaccines;2023-07-20

3. Randomised controlled trials in child and adolescent health in 2023;Archives of Disease in Childhood;2023-07-20